Advertisement
Advertisement
LYEL
Lyell Immunopharma, Inc. Common Stock
19.33
USDSponsored
-0.73
-3.64%
May 08, 15:59 UTC -4
Closed
Pre-Market
19.00
-0.33
-1.70%
Lyell Immunopharma, Inc. Common Stock Profile
About
Info & Links
CEO
Lynn Seely
Headquarters
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES
Industry
Sector
Website
Auditor
Ernst & Young LLP
Share holders
63
Employees
161
Lyell Immunopharma, Inc. Common Stock Statistics
Valuation Measures
Market Capitalization2
443.37M
Enterprise Value
383.19M
Enterprise Value/EBITDA(ttm)
-1.46
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
15.45K
Price to Book(mrq)
2.04
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
100.00%
Operating Margin(ttm)
-762355.56%
Profit Margin(ttm)
-970887.50%
Return on Equity(ttm)
-90.52%
Return on Invested Capital(ttm)
-98.29%
Return on Assets(ttm)
-70.22%
Income Statement
Revenue(ttm)
36.00K
Revenue Per Share(ttm)
0.00
Gross Profit(ttm)
36.00K
EBITDA(ttm)3
-262.82M
Net Income Available to Common(ttm)
-274.45M
Diluted EPS(ttm)
-16.30
Share Statistics
Beta (5Y Monthly)
-0.06
52-Week Change
141.62%
S&P 500 52-Week Change
26.60%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
23.31M
Dividend Yield
0.00%
Float4
18.13M
% Held by Insiders
22.30%
% Held by Institutions
66.05%
Balance Sheet
Total Cash(mrq)
247.22M
Total Cash Per Share(mrq)
10.61
Total Debt(mrq)
0.00
Total Debt/Equity(mrq)
0.00%
Current Ratio(mrq)
5.28%
Quick Ratio(mrq)
5.28%
Book Value Per Share(mrq)
11.68
Cash Flow
Operating Cash Flow Per Share(ytd)
-8.78
Free Cash Flow(ytd)
-191.71M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement